S&P 500 ends higher after Trump attacks Fed; Nvidia climbs

The S&P 500 advanced, buoyed by a 1.1% rise in Nvidia ahead of its pivotal earnings report and Eli Lilly's nearly 6% surge on promising experimental drug trial data. While President Trump's removal of a Fed governor sparked concerns over central bank independence, the market largely shrugged off the political interference, maintaining firm expectations for a 25-basis-point interest rate cut in September, driven by dovish Fed signals and labor market weakness. The S&P 500's current valuation at 23 times forward earnings highlights the significant impact Nvidia's results could have on the broader AI-fueled market rally.

Analysis

The U.S. market demonstrated resilience, with the S&P 500 closing up 0.41% despite political developments concerning Federal Reserve independence. Market participants appear to have priced in this political noise, focusing instead on the firm expectation of a 25-basis-point interest rate cut in September, a view reinforced by Morgan Stanley's recent forecast. The day's gains were largely driven by significant single-stock events, including a nearly 6% surge in Eli Lilly (LLY) following positive data for an experimental drug and a 70% rally in EchoStar (SATS) on news of a $23 billion asset sale to AT&T. Critically, Nvidia (NVDA) rose 1.1% in anticipation of its earnings report, an event that carries substantial market-wide implications. With the S&P 500 trading at a four-year high valuation of 23 times forward earnings, the market is highly sensitive to this report, which will serve as a key test for the sustainability of the AI-fueled rally. While market breadth was positive with a 1.1-to-one advance/decline ratio, trading volume was light at 15.7 billion shares, suggesting a degree of caution among investors.

Key Decisions for Investors

• Given the market's elevated valuation at 23 times forward earnings, investors should be prepared for significant volatility around Nvidia's upcoming earnings report, as its outcome could serve as a major catalyst or detractor for the entire AI sector.
• Investors should closely monitor upcoming inflation and employment data, as the market's current bullishness is heavily contingent on the expectation of a September rate cut, which could be swiftly repriced on stronger-than-expected economic figures.
• Consider looking for value in companies with strong idiosyncratic catalysts, such as the M&A activity driving EchoStar or the positive clinical trial results from Eli Lilly, which may offer performance drivers independent of the dominant AI and monetary policy narratives.